Telomeres are essential for chromosome stability. In the absence of telomere function chromosomes fuse and undergo other rearrangements and chromosome loss occurs. Evidence over the past seven years has suggested that maintenance of telomere length plays an important role in tumor progression and tumor growth. To probe the role of telomeres in normal cells and in tumor swe generated a telomerase null mouse in collaboration with Dr. Ronald DePinho's. Telomerase is a unique enzyme, requiring both a reverse transcriptase-like protein and a RNA component that synthesizes telomeres sequences onto chromosome ends. In the absence of telomerase, telomeres shorten progressively and telomere functions is lost after a number of cell divisions. The telomerase null mouse shows a progressive decrease in fertility and viability over six mouse generations. In the later generation, loss of cell viability is most apparent in highly proliferative organ systems. The loss of telomere function in late generation animal allows to study the fundamental consequences of the loss of telomere function in mammalian cells. In this application, we will address the role of checkpoint functions in loss of cell viability and probe the mechanisms that lead to chromosomal rearrangements. Our recent collaborative studies demonstrated that, in addition to a role in tumor growth, the absence of telomerase may lead to increased genetic instability and increased tumor formation. Thus the outcome of telomerase inhibition depends on the genetic background of the cell. Since telomerase inhibition is being pursued as an anti-cancer strategy, it is essential to understand in detail the consequence of telomerase inhibition in a variety of settings. In this application we propose to continue crosses of the telomerase null mouse to a variety of tumor prone mice to further explore the role of telomere function in tumor growth.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA016519-28
Application #
6580327
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-04-01
Project End
2003-03-31
Budget Start
Budget End
Support Year
28
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Janes, K; Symons-Liguori, A M; Jacobson, K A et al. (2016) Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics. Br J Pharmacol 173:1253-67
Oh, Sekyung; Kato, Masaki; Zhang, Chi et al. (2015) A Comparison of Ci/Gli Activity as Regulated by Sufu in Drosophila and Mammalian Hedgehog Response. PLoS One 10:e0135804
Price, Jessica C; Pollock, Lana M; Rudd, Meghan L et al. (2014) Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. PLoS One 8:e63313
O'Donnell, Kathryn A; An, Wenfeng; Schrum, Christina T et al. (2013) Controlled insertional mutagenesis using a LINE-1 (ORFeus) gene-trap mouse model. Proc Natl Acad Sci U S A 110:E2706-13
Newman, Robert H; Hu, Jianfei; Rho, Hee-Sool et al. (2013) Construction of human activity-based phosphorylation networks. Mol Syst Biol 9:655
Gnanakkan, Veena P; Jaffe, Andrew E; Dai, Lixin et al. (2013) TE-array--a high throughput tool to study transposon transcription. BMC Genomics 14:869
Rybanska-Spaeder, Ivana; Reynolds, Taylor L; Chou, Jeremy et al. (2013) 53BP1 is limiting for NHEJ repair in ATM-deficient model systems that are subjected to oncogenic stress or radiation. Mol Cancer Res 11:1223-34
O'Donnell, Kathryn A; Keng, Vincent W; York, Brian et al. (2012) A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci U S A 109:E1377-86
Burns, Kathleen H; Boeke, Jef D (2012) Human transposon tectonics. Cell 149:740-52
Dai, Lixin; Taylor, Martin S; O'Donnell, Kathryn A et al. (2012) Poly(A) binding protein C1 is essential for efficient L1 retrotransposition and affects L1 RNP formation. Mol Cell Biol 32:4323-36

Showing the most recent 10 out of 246 publications